The effect of different concentrations of MVC in the reactivation of latent NL4.3-wt HIV-1 strain was studied in CD4+ primary T lymphocytes treated with CCL19 or IL-7 before HIV-1 infection. This evidence concerns the gene CD4 and HIV-1 infection.